Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about New compound can reverse cataract
A team of scientists has identified a new chemical that can be used in eye drops to reverse cataracts which are a leading cause of blindness worldwide.
- Read more about Monkeys in Asia harbouring virus from humans
Researchers have found that monkeys which commonly dwell with people in Asia can harbour variants of a type of virus which can cause infectious gastroenteritis or diarrhoea in humans.
- Read more about Prakrit system of Ayurveda validated scientifically
A team of Indian scientists has provided scientific evidence for the Ayurvedic classification of Prakriti or the unique nature or constitution of an individual, a statement said on Thursday.
- Read more about Experts to focus on innovations in haematology
Experts, including specialists and doctors, will brainstorm on innovations, research and new findings in haematology, haemato-oncology, laboratory medicine and blood banking at the 56th annual conference of Indian Society of Haematology & Blood Transfusion, beginning here.
- Read more about Cabinet okays $750 mn investment by Dutch drug major
The union cabinet on Thursday approved $750 million (Rs.4,944 crore) investment by Dutch drug major Mylan Group B.V. Netherlands into its Indian subsidiary Mylan Laboratories Ltd.
- Read more about Vitamin D can prevent heart disease in chronic kidney disease patients
Taking Vitamin D supplements could prevent the development of heart disease in chronic kidney disease patients.
- Read more about Pesticides exposure may damage sperm in teenagers
Adolescent exposre to organochlorine pesticides such as DDT may lead to defective sperm and consequently fertility problems later in life, says a study.
- Read more about Merck's Glucophage(R) extended release (XR) can be used for more type 2 diabetes patients
Merck a leading science and technology company, announced that the British Medicines and Healthcare products Regulatory Agency (MHRA), has approved on November 2 an updated labeling for Glucophage® XR (extended release metformin) for the treatment of patients with type 2 diabetes. The label change removes moderate renal impairment stage 3a and stable chronic heart failure from the list of the contraindications of Glucophage® XR.

[adsense:336x280:8701650588]
- Read more about Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer(NSCLC)
Merck KGaA, Darmstadt, Germany, and Pfizer announced the initiation of an international Phase III study of the investigational cancer immunotherapy avelumab* in a treatment naïve advanced NSCLC setting. The study, JAVELIN Lung 100, is designed to assess the safety and efficacy of avelumab compared with platinum-based doublet chemotherapy, in patients with late-stage NSCLC who have not previously received any treatment for their systemic lung cancer. Avelumab (previously known as MSB0010718C) is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody that potentially uses the body’s own immune system to fight cancer.
- Read more about Johnson & Johnson announces agreement to acquire Novira Therapeutics, inc.
Johnson & Johnson announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection. The acquisition includes Novira’s portfolio of novel antivirals, including its lead candidate, NVR 3-778. Financial terms of the transaction have not been disclosed.